COMMUNIQUÉS West-GlobeNewswire

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
17/04/2026
Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase 3 development in DPNP New data on spasticity further validates the broader [...]
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
17/04/2026
EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between SRx Health Solutions and EMJX NORTH PALM BEACH, Fla., April 17, 2026 (GLOBE [...]
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
17/04/2026
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange [...]
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
17/04/2026
Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. ( [...]
First Steps Developmental Services Expands Services in Woburn
17/04/2026
New After-School and Hybrid Home ABA programs for children under 6 WOBURN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Families of young children with autism and Down syndrome in Massachusetts continue to face long [...]
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
17/04/2026
WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today [...]
Vistin Pharma ASA: Invitation to Q1 2026 conference call
17/04/2026
Oslo, Norway, 17 April 2026 Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 24th of April 2026. Vistin Pharma will host a conference call for all shareholders and interested parties on the [...]
New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles
17/04/2026
Report outlines 17 targeted actions to address structural barriers hindering leadership progression COPENHAGEN, Denmark and OSLO, Norway and STOCKHOLM, April 17, 2026 (GLOBE NEWSWIRE) -- The Nordic life science sector [...]
Immuron Double Digit 3Q Sales Growth
17/04/2026
Sales Highlights (unaudited): Global Q3 sales AUD$1.5 million up 16% on prior comparative period (pcp) YTD Mar 2026 sales AUD$5.7 million up 7% on prior comparative period (pcp) Australia Q3 sales AUD$0.9 million up 15 [...]
Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
17/04/2026
Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI therapy 44% ORR and 94% DCR in ccRCC patients previously treated with [...]
Carbios announces fiscal-year 2025 financial results
17/04/2026
Carbios significantly reduced its operating expenses during 2025, resulting in a €7 million reduction in operating loss Carbios has a solid cash position of €59 million as of December 31, 2025, on a Group basis [...]
Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
17/04/2026
Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with regulators on pivotal [...]
CARBIOS présente ses résultats annuels 2025
17/04/2026
Carbios a fortement réduit ses charges opérationnelles au cours de l’année 2025, permettant une réduction de la perte d’exploitation de 7 millions d’euros Carbios dispose d’une trésorerie solide à hauteur de 59 millions [...]
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
17/04/2026
NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
17/04/2026
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“ [...]
Kailera Therapeutics Announces Pricing of Initial Public Offering
17/04/2026
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced [...]
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
16/04/2026
Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31, 2026, in line with prior guidance for Q1. EDEN PRAIRIE, Minn., April 16, 2026 (GLOBE NEWSWIRE [...]
Raw Garden 4/20 Deals: Up to 60% Off California Cannabis
17/04/2026
Statewide retailer partnerships unlock limited-time 4/20 deals on single-source cannabis products from April 17–20 SANTA BARBARA, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Raw Garden ® , California’s leading clean [...]
OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research
16/04/2026
A Peak Health Research informational report on OsteoShield's bone density support formulation, Aquamin marine mineral complex, Palm-Collagen blend, zombie cell inflammation research context, ingredient dosage [...]

Pages